TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
KRYS

Krystal Biotech Inc

Healthcare · Biotechnology

350.90$ +5.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement KRYS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-100.0% +473.0% +33.9%
+1,050.0% +513.0% +590.8% +90.0% +49.6% +46.4% -23.7% +548.4% +43.4%
-209.9% +468.1% +33.2%
+332.9% +141.9% +101.2% +14.9% +55.5% +52.3% +9.3% +15.4% +8.3%
+289.1% +165.7% +55.6% +133.0% +168.1% +92.5% +26.6% +15.5% +29.1%
+317.5% +149.7% +85.3% +41.1% +119.2% +112.7% +8.4% +30.1% -2.8%
+145.5%
+44,871.4% -67.4% -100.0% +79.3% +249.9% -100.0%
+639.4% +98.7%
+185.5% +66.0% +1,147.4% -94.2% +215.4% -347.9%
+715.6% +129.7%
+78.3%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?